Permanent neonatal diabetes caused by an in-frame deletion in the N-terminus of Kir6.2

被引：0
|
作者：
Craig, T. J. [1 ]
Shimomura, K. [1 ]
Flanagan, S. [2 ]
Ellard, S. [2 ]
Hattersley, A. [2 ]
Ashcroft, F. M. [1 ]
机构：
[1] Univ Oxford, Exeter, Devon, England
[2] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
239
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [1] An In-Frame Deletion in Kir6.2 (KCNJ11) Causing Neonatal Diabetes Reveals a Site of Interaction between Kir6.2 and SUR1
    Craig, Tim J.
    Shimomura, Kenju
    Holl, Reinhard W.
    Flanagan, Sarah E.
    Ellard, Sian
    Ashcroft, Frances M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (07): : 2551 - 2557
  • [2] Involvement of the N-terminus of Kir6.2 in coupling to the sulphonylurea receptor
    Reimann, F
    Tucker, SJ
    Proks, P
    Ashcroft, FM
    JOURNAL OF PHYSIOLOGY-LONDON, 1999, 518 (02): : 325 - 336
  • [3] Involvement of the N-terminus of Kir6.2 in the inhibition of the KATP channel by ATP
    Proks, P
    Gribble, FM
    Adhikari, R
    Tucker, SJ
    Ashcroft, FM
    JOURNAL OF PHYSIOLOGY-LONDON, 1999, 514 (01): : 19 - 25
  • [4] The N-terminus of Kir6.2 is involved in coupling to SUR1
    Reimann, F
    Proks, P
    Tucker, SJ
    Ashcroft, FM
    BIOPHYSICAL JOURNAL, 1999, 76 (01) : A14 - A14
  • [5] Importance of the KIR6.2 N-terminus for inhibition of the pancreatic KATP channels by glibenclamide and repaglinide
    Russ, U
    Prager, R
    Stephan, D
    Bryan, J
    Quast, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 64 - 64
  • [6] Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic KATP channel
    Petra Kühner
    Renate Prager
    Damian Stephan
    Ulrich Russ
    Marcus Winkler
    David Ortiz
    Joseph Bryan
    Ulrich Quast
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385 : 299 - 311
  • [7] Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic KATP channel
    Kuehner, Petra
    Prager, Renate
    Stephan, Damian
    Russ, Ulrich
    Winkler, Marcus
    Ortiz, David
    Bryan, Joseph
    Quast, Ulrich
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 (03) : 299 - 311
  • [8] The impact of the KIR6.2 N-terminus for inhibitor binding to the ATP-sensitive potassium channel
    Stephan, D
    Winkler, M
    Russ, U
    Bryan, J
    Quast, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R58 - R58
  • [9] Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2
    Zung, A
    Glaser, B
    Nimri, R
    Zadik, Z
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5504 - 5507
  • [10] Kir6.2 mutations search in patients with permanent neonatal diabetes from a Polish population
    Klupa, T
    Flanagan, S
    Nazim, J
    Ellard, S
    Ciechanowska, M
    Starzyk, J
    Sieradzki, J
    Hattersley, AT
    Malecki, MT
    DIABETOLOGIA, 2005, 48 : A112 - A113
12345